[DOI] [PubMed] [Google Scholar] Carrasco J, Anglada FJ, Campos JP, Muntan J, Requena MJ, Padillo J
In a 12-week study of patients with rosacea, 70% of study subjects showed significant improvement, with 50% going from mild to almost gone in 12 weeks
For doses above 0.2 mg, semaglutide resulted in a dose-dependent reduction in HbA1c up to 1.7% (compared to a 0.5% reduction with placebo)
Website is great as well and great choice and selection of coffee
Over one year, liraglutide did not significantly improve the primary endpoint (change in cerebral glucose metabolic rate in certain brain regions), but secondary endpointsincluding brain volume loss, and cognitive measuresshowed benefit: ~50% less loss in several brain regions compared to placebo